Nexus Pharmaceuticals, Inc. Receives Successful FDA Inspection of Pharmaceutical Manufacturing Facility in Pleasant Prairie, Wisconsin

Date Published05/05/2023

Additional Reshoring Information:

Company/Division name Nexus Pharmaceuticals Inc.
Parent companyNexus Pharmaceuticals Inc.
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2023
Year reshoring implemented or to be implemented:2023
City reshored to:Pleasant Prairie
State(s) reshored to:WI
If relevant, work nearshored to:-
Product(s) reshoredsterile pharmaceutical manufacturing
What non-domestic negative factors made offshoring less attractive?Quality/rework/warranty, Regulatory compliance, Supply chain interruption
What domestic positive factors made reshoring more attractive?Eco-system synergies
Find Reshoring Articles